CS226945B1 - Method of preparing hydroxyeburnate - Google Patents
Method of preparing hydroxyeburnate Download PDFInfo
- Publication number
- CS226945B1 CS226945B1 CS574482A CS574482A CS226945B1 CS 226945 B1 CS226945 B1 CS 226945B1 CS 574482 A CS574482 A CS 574482A CS 574482 A CS574482 A CS 574482A CS 226945 B1 CS226945 B1 CS 226945B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- configuration
- formula
- hmpa
- hydrogen atom
- methoxycarbonyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 9
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims description 8
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 5
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960002726 vincamine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RXPRRQLKFXBCSJ-HLAWJBBLSA-N 16-epivincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-HLAWJBBLSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- BOAFIDYFQWIRTC-QFUCXCTJSA-N deoxyvincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@H](C(=O)OC)N5C2=C1 BOAFIDYFQWIRTC-QFUCXCTJSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Vynález se týká způsobu výroby hydroxyeburnanů obecného vzorce I,The invention relates to a process for the preparation of hydroxyeburnanes of the general formula I,
ve kterém R1 značí atom vodíku s konfigurací a nebo β, R2 skupinu hydroxylovou v případě, že R3 znamená skupinu methoxykarbonylovou nebo ethoxykarbonylovou, nebo R2 znamená skupinu methoxykarbonylovou či ethoxykarbonylovou v případě, že R3 značí skupinu hydroxylovou, a to jak jejich raceimáitů, tak opticky aktivních forem.in which R 1 represents a hydrogen atom with the configuration or β, R 2 OH group when R 3 represents a methoxycarbonyl or ethoxycarbonyl, or R2 is methoxycarbonyl or ethoxycarbonyl, where R 3 represents a hydroxyl group, both their raceimaids and optically active forms.
Sloučeniny obecného vzorce I, které vynikají významnou cerebrovaskuiární aktivitou, jsou vesměs známé. Jedna z těchto sloučenin, vinkamin (I, R1 = «Η, R2 = OH, R3 — COOCH3J je důležitým léčivem této indikační oblasti. Uvedené sloučeniny mo2 hou také sloužit jako cenné suroviny pro výrobu dalších účinných léčiv.Compounds of formula I which exhibit significant cerebrovascular activity are generally known. One of these compounds, vincamine (I, R 1 = Η, R 2 = OH, R 3 - COOCH 3 J) is an important drug in this indication area, and these compounds can also serve as valuable raw materials for the production of other active drugs.
Podle postupu uvedeném v čs. patentovém spisu č. 189 620 se vyrábí směs vinkaminu '(I, R1 = «Η, R2 = OH, R3 = COOCH3) a jeho stereoisomeru 16-epivinkaminu (I, R1 — = «Η, R2 = COOCH3 a R3 = OH) tak, že se na deoxyvinkamin vzorce II,According to the procedure in MS. No. 189,620 produces a mixture of vincamine (I, R 1 = Η, R 2 = OH, R 3 = COOCH 3 ) and its stereoisomer of 16-epivincamine (I, R 1 = Η, R 2 = (COOCH 3 and R 3 = OH) by reacting to deoxyvincamine of formula II,
kde R1 značí atom vodíku s konfigurací a a R2‘ skupinu methoxykarbonylovou s konfigurací -a, působí v aprotickém rozpouštědle silnou organickou bází a pak molekulárním kyslíkem. Výtěžky nejsou uvedeny. Při reprodukci tohoto postupu bylo zjištěno, že výtěžky žádaných produktů jsou velmi níz.....1 ké. Další nevýhodou uvedeného postupu je dlouhá reakční doba oxidačního stupně. Cílem tohoto vynálezu je odstranění těchto nevýhod.where R @ 1 represents a hydrogen atom in the aa configuration and R @ 2 'represents a methoxy group having the -a configuration, acts in the aprotic solvent with a strong organic base and then with molecular oxygen. Yields not shown. In reproducing this process, it was found that the yields of the desired products were very low. A further disadvantage of said process is the long reaction time of the oxidation stage. It is an object of the present invention to overcome these disadvantages.
Podstata způsobu výroby podle vynálezu spočívá v tom, že se na racemáty nebo opticky aktivní formy esterů 16-karboxyeburnanů obecného vzorce II, ve kterém R1 značí atom vodíku s konfigurací α nebo β a R2‘ skupinu methoxykarbonylovou či ethoxykarbonylovou s konfigurací a nebo β, působí v aprotickém rozpouštědle, jako např. bezvodém tetrahydrofuranu, triamidu kyseliny hexamethylfosforečné nebo v jejich směsích, silnou organickou bází, natpř. líthiumdiisopropylamidem při teplotách od —78 do +100 °C s výhodou při 0 °C, s následující oxidací peroxidem molybdenu ve i formě komplexu vzorce III,The process according to the invention is characterized in that the racemates or optically active forms of the esters of the 16-carboxyeburnanes of the formula II in which R @ 1 represents a hydrogen atom having the α or β configuration and R @ 2 'are a methoxy or ethoxycarbonyl group having the. , in strong aprotic solvent, such as anhydrous tetrahydrofuran, hexamethylphosphoric triamide or mixtures thereof, with a strong organic base, e.g. lithium diisopropylamide at temperatures from -78 to +100 ° C, preferably at 0 ° C, followed by oxidation with molybdenum peroxide as the complex of formula III,
MoO5.Py.HMPA (III) kde Py značí pyridin a HMPA triamid kyseliny hexamethylfosforečné.MoO5.Py.HMPA (III) wherein Py is pyridine and HMPA is hexamethylphosphoric triamide.
Následující příklady ilustrují, avšak nikterak neomezují obecnnost způsobu výroby podle vynálezu.The following examples illustrate but do not limit the generality of the process of the invention.
Pří klad 1Example 1
K roztoku lithiumdiisopropylamidu připraveného z diisopropylaminu (0,3 ml, 2,1 mmol) a 15% roztoku butyllithia (1,4 ml,To a solution of lithium diisopropylamide prepared from diisopropylamine (0.3 mL, 2.1 mmol) and 15% butyllithium solution (1.4 mL,
2,25 mmol) v tetrahydrofuranu (3,0 ml) při 0 °C byl přikapán roztok 0,2 g (0,6 mmol) ( + )-methyl-deoxyvinkaminátu (II, R1 = «Η, R2‘ — aCOOCH3) v tetrahydrofuranu (8,0 mililitrů) a reakční směs byla míchána při 0 °C 0,5 h. Po jednorázovém přidání komplexního činidla MoO5.Py.HMPA (0,28 g) bylo v míchání pokračováno dalších 0,25 h při 0 °C a 0,25 h při 20 °C. Roztok byl znovu ochlazen na 0 °C, po přidání dalších 0,12 gramů oxidačního činidla míchán ještě 2 h při 20 °C. Reakční směs byla rozložena 5 milililtry vody, fáze byly odděleny a vodná vrstva byla vyextrahována chloroformem. Spojené organické fáze byly odpařeny do sucha a odjparek byl chromatografován na sloupci silikagelu. Zpracováním příslušných chloroiform-methanolových frakcí bylo získáno 8,1 mg (+)-vinkaminu (I, R1 — = aH, R2 = OH, R3 = COOCH3) o teplotě, tání 232 až 234 °C, a 84,5 mg (—)-16-epivinkaminu (I, R1 = «Η, R2 = COOCH3, R3 = = OH) o teplotě tání 188 až 190 °C.2.25 mmol) in tetrahydrofuran (3.0 mL) at 0 ° C was added dropwise a solution of 0.2 g (0.6 mmol) of (+) - methyl-deoxyvincaminate (II, R 1 = Η, R 2 '- aCOOCH 3). ) in tetrahydrofuran (8.0 mL) and the reaction mixture was stirred at 0 ° C for 0.5 h. After a single addition of MoO5.Py.HMPA complex reagent (0.28 g), stirring was continued for an additional 0.25 h at 0 ° C. ° C and 0.25 h at 20 ° C. The solution was recooled to 0 ° C, stirred for an additional 2 hours at 20 ° C after the addition of an additional 0.12 grams of oxidizing agent. The reaction mixture was quenched with 5 milliliter of water, the phases were separated and the aqueous layer was extracted with chloroform. The combined organic phases were evaporated to dryness and the residue was chromatographed on a silica gel column. Treatment of the methanol-chloroiform relevant fractions yielded 8.1 mg (+) - vincamine (I, R 1 - = H, R 2 = OH, R 3 = COOCH 3) melting, m.p. 232-234 ° C, 84.5 mg (-) - 16-epivincamine (I, R 1 = Η, R 2 = COOCH 3 , R 3 = = OH), m.p. 188-190 ° C.
Příklad 2Example 2
K roztoku lithiumdiisopropylamidu připraveného z diisopropylaminu (0,5 mlj v tetrahydrofuranu (5 ml) a 15% 'roztoku butyllithia v hexanu (2,5 ml) při 0 °C byl přikapán roztok . 0,35 g ( + ]-21/3,16/3-ethoxykarbonyleburnanu (II, R1 — /3H, R2 = = /ICOOCaHs) v 5 ml tetrahydrofuranu a reakční směs byla míchána při 0 °C 0,5 h. Pak bylo přidáno způsobem uvedeným v příkladu 1 celkem 0,675 g oxidačního komplexu MoO5. Py . HMPA. Reakční směs byla míchána při laboratorní teplotě 2,5 h, pak rozložena v 7 ml vody a zpracována jako v příkladu 1. Byl získán (+)-ethyl-16-epi,21-epivinkaminát (I, R1 = j3H, R2 = COOC2H5, r3 — on) s teplotou tání 146 až 148 °C a ( + )-ethyl-21-epivinkaminát (I, R1 = /3H, R2 = OH, R3 = COOC‘?H5) o teplotě tání 181 až 183 °C.To a solution of lithium diisopropylamide prepared from diisopropylamine (0.5 mL in tetrahydrofuran (5 mL) and a 15% solution of butyllithium in hexane (2.5 mL) at 0 ° C was added dropwise a solution. 0.35 g (+] -21/3 16/3-ethoxykarbonyleburnanu (II, R 1 - / 3 H, R 2 = / ICOOCaHs) in 5 ml of tetrahydrofuran and the mixture was stirred at 0 ° C for 0.5 hr. was then added as described in Example 1 of 0,675 g MoO complex oxidizing fifth Py. HMPA. the reaction mixture was stirred at room temperature for 2.5 hours, then quenched in 7 ml water and treated as in Example 1 gave (+) - ethyl-16-epi, 21-epivincamine (I, R 1 = j3H R2 = COOC2H5, R 3 - one), m.p. 146-148 ° C and (+) ethyl-21-epivincamine (I, R = 1/3 H, R 2 = OH, R 3 = COOC (2H) m.p. 181-183 ° C.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS574482A CS226945B1 (en) | 1982-07-30 | 1982-07-30 | Method of preparing hydroxyeburnate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS574482A CS226945B1 (en) | 1982-07-30 | 1982-07-30 | Method of preparing hydroxyeburnate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS226945B1 true CS226945B1 (en) | 1984-04-16 |
Family
ID=5402914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS574482A CS226945B1 (en) | 1982-07-30 | 1982-07-30 | Method of preparing hydroxyeburnate |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS226945B1 (en) |
-
1982
- 1982-07-30 CS CS574482A patent/CS226945B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101065396B (en) | The preparation method of drospirenone | |
| JPS6372674A (en) | Dihydropyridine compounds | |
| Djerassi et al. | A New Route to 1-Oxygenated Steroids1 | |
| EP0080381B1 (en) | Homobrassinolide, and its production and use | |
| CS226945B1 (en) | Method of preparing hydroxyeburnate | |
| US3247189A (en) | 3, 19 and 20 oxygenated-delta5-pregnenes | |
| US4163744A (en) | Synthesis of steroids | |
| US3847906A (en) | Process for the manufacture of beta-(3-oxo-7alpha-acetylthio-17beta-hydroxy-4-androsten-17alpha-yl)-propionic acid gamma-lactone | |
| EP0257503B1 (en) | Process for the production of optically active hydroquinone derivatives and d-alpha-tocopherol | |
| Fujita et al. | Terpenoids. Part 39. Total synthesis of gibberellins A 15 and A 37 | |
| EP0695290B1 (en) | N-fluorosulphonimides, method of preparing them and their use as fluorination agents | |
| SU602120A3 (en) | Method of producing 17-beta-oxalylsteroids | |
| US3468918A (en) | Process for preparing delta14-3,20-diketo-21-acyl-steroids | |
| SU799660A3 (en) | Method of preparing 5/6-(cyclopropylethyl)-sulfinyl/-benzimidazole-2-methylcarbamate | |
| Anastasia et al. | A novel synthesis of 3β-hydroxy-5α-cholest-8 (14)-en-15-one | |
| JPH0588230B2 (en) | ||
| DE2302970A1 (en) | METHOD FOR PRODUCING HETEROCYCLIC COMPOUNDS | |
| TAHARA | Santonin and Related Compounds. VII. Diketo Acids from Tetrahydrosantonins | |
| US2931806A (en) | dl-delta5-3-ethylenedioxy-11-keto-20-cyano pregnenes | |
| SU946404A3 (en) | Process for producing steroid (16 alpha 17 beta)cyclohexane- or naphthalene-21-carboxylic acids or their esters | |
| US3238234A (en) | Hemi-esters and phosphates of 19-norpregnan-21-ol-3, 20-dione and metallic salts thereof | |
| US4117245A (en) | Process for the production of norpatchoulenol | |
| US3865854A (en) | Process of preparation of alkyl tridecatrienoates and intermediates | |
| DE2543732A1 (en) | DERIVATIVES OF 3ALPHA,5ALPHA-CYCLO-6BETA-ALKOXY-25-HYDROXYCHOLESTEROL AND 3ALPHA,5ALPHA-CYCLO-6BETA-ALKOXYCHOLEST-22T-EN-24,25-OXIDE, METHOD FOR PRODUCING THE SAME AND INTERMEDIATE PRODUCTS FOR HYDROXYLATED VITA MIN D LOW 2 AND D DEEP 3 | |
| DE1643013C3 (en) | Process for the preparation of butenolides |